The neurobiology of eating disorders-a clinical perspective

Acta Psychiatrica Scandinavica

Volumn 131, Issue 4, 2015, Pages 244-255

  von Hausswolff Juhlin, Yvonne ^a,b   Brooks, S J ^a,c   Larsson, M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Stockholm Centre for Eating Disorders   (Sweden)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Comorbidity; Eating disorder; Neurobiology; Neuroimaging; Psychopharmacology

Indexed keywords

NEUROPEPTIDE; SEROTONIN;

APPETITE; CLINICAL RESEARCH; COMORBIDITY; DOPAMINERGIC TRANSMISSION; EARLY INTERVENTION; EATING DISORDER; FAMILY THERAPY; HUMAN; HYPERTENSION; INSULA; INSULIN RESISTANCE; MENTAL DISEASE; METABOLIC SYNDROME X; NEUROBIOLOGY; NEUROIMAGING; NEUROPSYCHOLOGY; NORADRENERGIC SYSTEM; OBESITY; PRIORITY JOURNAL; REVIEW; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

EATING DISORDERS; HUMANS; NEUROIMAGING;

EID: 84924567648     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12335     Document Type: Review

References (147)

1. Gustavsson A. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718-779.
2. Machado PP. The prevalence of eating disorders not otherwise specified. Int J Eat Disord 2007;40:212-217.
3. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eatingdisorders. Curr Opin Psychiatry 2006;19:389-394.
4. Currin L. Time trends in eating disorder incidence. Br J Psychiatry 2005;186:132-135.
5. Agras WS. The Oxford handbook of eating disorders. New York: Oxford University Press, 2010: pp 25-32.
6. Mond JM, Arrighi A. Gender differences in perceptions of the severity and prevalence of eating disorders. Early Interv Psychiatry 2011;5:41-49.
7. Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998;173:11-53.
8. Arcelus J. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry 2011;68:724-731.
9. Maxwell M. Life beyond the eating disorder: education, relationships, and reproduction. Int J Eat Disord 2011;44:225-232.
10. Pinheiro AP. Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet 2010;153:1070-1080.
11. Lilenfeld LR. A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 1998;55:603-610.
12. Button E, Aldrige S. Season of birth and eating disorders: patterns across diagnoses in a specialized eating disorders service. Int J Eat Disord 2007;40:468-471.
13. Stefano GB, Ptacek R. Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders. Med Sci Monit 2013;10:353-358.
14. Kaye WH. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry 2004;161:2215-2221.
15. Halmi KA. Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs. Arch Gen Psychiatry 2005;62:776-781.
16. Fassino S. Baseline personality characteristics of responders to 6-month psychotherapy in eating disorders: preliminary data. Eat Weight Disord 2005;10:40-50.
17. Deter HC. Predictability of a favorable outcome in anorexia nervosa. Eur Psychiatry 2005;20:65-72.
18. Santonastaso P. Prevalence of eating disorders in Italy: a survey on a sample of 16-year-old female students. Psychother Psychosom 1996;65:158-162.
19. Hudson JI. By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder? Int J Eat Disord 2012;45:139-141.
20. Fairburn CG, Cooper Z. Eating disorders, DSM-5 and clinical reality. Br J Psychiatry 2014;198:8-10.
21. Wade TD. An examination of the overlap between genetic and environmental risk factors for intentional weight loss and overeating. Int J Eat Disord 2009;42:492-497.
22. Meczekalski B, Podfigurna-Stopa A. Long-term consequences of anorexia nervosa. Maturitas 2013;75:215-220.
23. Dynesen AW. Salivary changes and dental erosion in bulimia nervosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:696-707.
24. Dougall A, Fiske J. Access to special care dentistry, part 6. Special care dentistry services for young people. Br Dent J 2008;205:235-249.
25. Roehrig M. The metabolic syndrome and behavioral correlates in obese patients with binge eating disorder. Obesity (Silver Spring) 2009;17:481-486.
26. Sansone RA. The prevalence of binge eating disorder and borderline personality symptomatology among gastric surgery patients. Eat Behav 2008;9:197-202.
27. Fisher CA, Hetrick SE, Rushford N.Family therapy for anorexia nervosa. Cochrane Database Syst Rev 2010;(14):CD004780.
28. Hudson JI. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;61:348-358.
29. Hay PP. Psychological treatments for bulimia nervosa and binging. Cochrane Database Syst Rev 2009;(4):CD000562.
30. Aigner M, Treasure J, Kaye W, Kasper S, WFSBP Task Force On Eating Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry 2011;2:400-443.
31. Mitchell JE. Drug therapy for patients with eating disorders. Curr Drug Targets CNS Neurol Disord 2003;2:17-29.
32. Blinder BJ. Psychiatric comorbidities of female inpatients with eating disorders. Psychosom Med 2006;68:454-462.
33. Godart NT. Anxiety disorders in subjects seeking treatment for eating disorders: a DSM-IV controlled study. Psychiatry Res 2003;117:245-258.
34. Geist R, Davis R, Heinmaa M. Binge/purge symptoms and comorbidity in adolescents with eating disorders. Can J Psychiatry 1998;43:507-512.
35. Hughes EK, Goldschmidt AB. Eating disorders with and without comorbid depression and anxiety: similarities and differences in a clinical sample of children and adolescents. Eur Eat Disord Rev 2013;21:386-394.
36. Norring C, Paler RL. Eating disorders not otherwise specified. New York: Routledge, 2005.
37. Preti A. The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res 2009;43:1125-1132.
38. Javaras KN. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry 2008;69:266-273.
39. Miettunen J, Ravuori A. A meta-analysis of temperament in axis I psychiatric disorders. Compr Psychiatry 2012;53:152-166.
40. Wentz E. Childhood onset neuropsychiatric disorders in adult eating disorder patients. A pilot study. Eur Child Adolesc Psychiatry 2005;14:431-437.
41. Rastam M. Anorexia nervosa in 51 Swedish adolescents: premorbid problems and comorbidity. J Am Acad Child Adolesc Psychiatry 1992;31:819-829.
42. Power RA. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry 2013;70:22-30.
43. Bou Khalil R, Hachem D, Richa S. Eating disorders and schizophrenia in male patients: a review. Eat Weight Disord 2011;16:150-156.
44. Kaye WH. Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa? Biol Psychiatry 2013;73:836-842.
45. Rodin G. Eating disorders in young women with type 1 diabetes mellitus. J Psychosom Res 2002;53:943-949.
46. Arigo D, Anskis AM, Smyth JM. Psychiatric comorbidities in women with Celiac disease. Chronic Illn 2012;8:45-55.
47. Naesen S. Polycystic ovary syndrome in bulimic women-an evaluation based on the new diagnostic criteria. Gynecol Endocrinol 2006;22:388-394.
48. Chipkevitch E, Fernandes AC. Hypothalamic tumor associated with atypical forms of anorexia nervosa and diencephalic syndrome. Arq Neuropsiquiatr 1993;51:270-274.
49. Keys A, Brozek J. The biology of human starvation, Vol. 2. Minneapolis: University of Minnesota Press, 1950.
50. Gillberg IC. The cognitive profile of anorexia nervosa: a comparative study including a community-based sample. Compr Psychiatry 1996;37:23-30.
51. Tchanturia K. Neuropsychological studies in anorexia nervosa. Int J Eat Disord 2005;37:87-89.
52. Oldershaw A. Emotional processing following recovery from anorexia nervosa. Eur eat Disord Rev 2012;20:502-509.
53. Holliday J. Is impaired set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry 2006;62:2269-2275.
54. Rose M. A case series investigating distinct neuropsychological profiles in children and adolescents with anorexia nervosa. Eur Eat Disord Rev 2012;20:32-38.
55. Kaye WH. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009;10:573-584.
56. Costafreda SG. Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnoses. J Affect Disord 2013;150:96-103.
57. Brooks SJ, O'Daly OG. Subliminalfood images compromise superior working memory performance in women with restricting anorexia nervosa. Conscious Cogn 2012;21:751-763.
58. Clark-Stone S, Joyce H. Understanding eating disorders. Nurs Times 2003;99:20-23.
59. Shafran R. Body checking and its avoidance in eating disorders. Int J Eat Disord 2004;35:93-101.
60. Treasure J, Campbell I. The case for biology in the aetiology of anorexia nervosa. Psychol Med 1994;24:3-8.
61. Lauzon CS. Simultaneous analysis and quality assurance for diffusion tensor imaging. PLoS ONE 2013;30:61737.
62. Jezzard P, Buxton RB. The clinical potential of functional magnetic resonance imaging. J Magn Reson Imaging 2006;23:787-793.
63. Kwee TC. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification. J Thorac Imaging 2013;28:4-10.
64. Titova OE. Anorexia nervosa is linked to reduced brain structure in reward and somatosensory regions: a meta-analysis of VBM studies. BMC Psychiatry 2013;9:103-110.
65. Lambe EK. Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Arch Gen Psychiatry 1997;54:537-542.
66. Artmann H. Reversible and non-reversible enlargement of cerebrospinal fluid spaces in anorexia nervosa. Neuroradiology 1985;27:304-312.
67. Krieg JC. Structural brain abnormalities in patients with bulimia nervosa. Psychiatry Res 1989;27:39-48.
68. Kiriike N. Ventricular enlargement in normal weight bulimia. Acta Psychiatr Scand 1990;82:264-266.
69. Uher RM, Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry 2005;76:852-857.
70. Delvenne V. Brain glucose metabolism in anorexia nervosa and affective disorders: influence of weight loss or depressive symptomatology. Psychiatry Res 1994;74:83-92.
71. Nozoe S. Comparison of regional cerebral blood flow in patients with eating disorders. Brain Res Bull 1995;36:251-255.
72. McGlynn SM, Schacter DL. Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol 1989;11:143-205.
73. Delvenne V. Brain hypometabolism of glucose in low-weight depressed patients in anorectic patients: a consequence of starvation? J Affect Disord 1997;44:69-77.
74. Naruro T. Decreases in blood perfusion of the anterior cingulate gyri in anorexia nervosa restricters assessed by SPECT image analysis. BMC Psychiatry 2001;1:2.
75. Delvenne V. Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain. Biol Psychiatry 1996;40:761-768.
76. Miller KK. Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa. Psychiatry Res 2004;132:197-207.
77. Rastam M. Regional cerebral blood flow in weight-restored anorexia nervosa: a preliminary study. Dev Med Child Neurol 2001;43:239-242.
78. Zald DH, Kim SW. Anatomy and function of the orbital frontal cortex, I: anatomy, neurocircuitry; and obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1996;8:125-138.
79. Kringelbach ML, Rolls ET. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol 2004;72:341-372.
80. Brooks SJ. Restraint of appetite and reduced regional brain volumes in anorexia nervosa: a voxel-based morphometric study. BMC Psychiatry 2011;17:179.
81. Titova OE. Anorexia nervosa is linked to reduced brain structure in reward and somatosensory regions: a meta-analysis of VBM studies. BMC Psychiatry 2013;13:110.
82. Brooks SJ. Thinking about eating food activates visual cortex with reduced bilateral cerebellar activation in females with anorexia nervosa: an fMRI study. PLoS ONE 2012;7:34000.
83. Uher R. Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry 2003;54:934-942.
84. Uher R. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry 2004;161:1238-1246.
85. Pepin G. Come play with me: an argument to link autism spectrum disorders and anorexia nervosa through early childhood pretend play. Eat Disord 2012;20:254-259.
86. Fonville L. Alterations in brain structure in adults with anorexia nervosa and the impact of illness duration. Psychol Med 2013;27:1-11.
87. Martinez G. Anorexia nervosa in the light of neurocognitive functioning: new theoretical and therapeutic perspective. Encephale 2013;28:160-167.
88. Nozoe S. Changes in regional cerebral blood flow in patients with anorexia nervosa detected through single photon emission tomography imaging. Biol Psychiatry 1993;34:578-580.
89. Gordon CM. Neural substrates of anorexia nervosa: a behavioral challenge study with positron emission tomography. J Pediatr 2001;139:51-57.
90. Schulte-Ruther M. Theory of mind and the brain in anorexia nervosa: relation treatment outcome. J Am Acad Child Adolesc Psychiatry 2012;51:832-841.
91. Kojima S. Comparison of regional cerebral blood flow in patients with anorexia nervosa before and after weight gain. Psychiatry Res 2005;140:251-258.
92. Galusca B. Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study. Biol Psychiatry 2008;64:1009-1013.
93. Audenaert K. Decreased 5-HT2a binding in patients with anorexia nervosa. J Nucl Med 2003;44:163-169.
94. Bailer UF. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 2004;29:1143-1155.
95. Bailer UF. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 2007;61:1090-1099.
96. Frank GK. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 2002;52:896-906.
97. Klump KL. Personality characteristics of women before and after recovery from an eating disorder. Psychol Med 2004;34:1407-1418.
98. Bailer UF. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 2005;62:1032-1041.
99. Mann JJ. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 1999;21:99-105.
100. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998;44:151-162.
101. Highley JD, Dinnoila L. Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann N Y Acad Sci 1997;836:39-56.
102. Lesch KP, Merschdorf U. Impulsivity, aggression, and serotonin: a psychobiological perspective. Behav Sci Law 2000;18:581-604.
103. Serpell L. Anorexia nervosa: obsessive-compulsive disorder, personality disorder or neither? Clin Psychol Rev 2002;22:647-669.
104. Mann J, Thakore JH. Melancholic depression and abdominal fat distribution: a mini-review. Stress 1999;3:1-15.
105. Simansky KJ. Serotonergic control of the organization of feeding and satiety. Behav Brain Res 1996;73:37-42.
106. Soubrie P. Serotonergic neurons and behavior. J Pharmacol 1986;17:107-112.
107. Kaye WH. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 2005;85:73-81.
108. Kaye WH. Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. Int J Eat Disord 2003;33:257-267; discussion 268-270.
109. Vitousek K, Manke F. Personality variables and disorders in anorexia nervosa and bulimia nervosa. J Abnorm Psychol 1994;103:137-147.
110. Kaye WH. Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 1991;48:556-562.
111. Tammella LI. Treatment improves serotonin transporter binding and reduces binge eating. Psychopharmacology 2003;170:89-93.
112. Bailer UF. Serotonin transporter binding after recovery from eating disorders. Psychopharmacology 2007;195:315-324.
113. File SE. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav 2000;66:65-72.
114. Tauscher J. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 2001;158:1326-1328.
115. Moresco FM. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage 2002;17:1470-1478.
116. Walsh BT. Fluoxetine after weight testoration in anorexia nervosa. JAMA 2006;296:934.
117. Duvvuri V. 5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition. Pharmacol Biochem Behav 2009;93:349-353.
118. Daw ND. Opponent interactions between serotonin and dopamine. Neural Netw 2002;15:603-616.
119. Schwighofer N. Serotonin and the evaluation of future rewards: theory, experiments, and possible neural mechanisms. Ann N Y Acad Sci 2007;1104:289-300.
120. Ernst M. Choice selection and reward anticipation: an fMRI study. Neuropsychologica 2004;42:1585-1597.
121. Westergaard GC. Physiological correlates of aggression and impulsivity in free-ranging female primates. Neuropsychopharmacology 2003;28:1045-1055.
122. Tiihonen J. Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 2004;55:871-873.
123. Tauscher J. [1231I] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa. Biol Psychiatry 2001;49:326-332.
124. Steinglass J, Walsh BT. Habit learning and anorexia nervosa: a cognitive neuroscience hypothesis. Int J Eat Disord 2006;39:267-275.
125. Frank G. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry 2005;58:908-912.
126. Wagner A. Altered reward processing in women recovered from anorexia nervosa. Am J Psychiatry. 2007;164:1842-1849.
127. Wang GJ. Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring) 2011;19:1601-1608.
128. Glashouwer KA. Heightened sensitivity to punishment and reward in anorexia nervosa. Appetite 2010;75:97-102.
129. Macovenau J. Serotonergic modulation of reward and punishment: evidence from pharmacological fMRI studies. Brain Res 2014;27:19-27.
130. Bailder UF. A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Curr Drug Targets CNS Neurol Disord 2003;2:53-59.
131. Chattopadhyaya B. GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 2007;54:889.
132. Baranowska B. The role of leptin and orexins in the dysfunction of hypothalamo-pituitary-gonadal regulation and in the mechanism of hyperactivity in patients with anorexia nervosa. Neuro Endocrinol Lett 2008;29:37-40.
133. Prince J. Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr 2009;89:755-765.
134. Wookey PJ. Amylin in the periphery II: an updated mini-review. ScientificWorldJournal 2006;15:1642-1655.
135. Meier U. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511-1525.
136. Tschop M. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-709.
137. Muller AF. Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol 2002;146:203-207.
138. Otto B. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001;145:669-673.
139. Tanaka M. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002;146:1-3.
140. Monteleone P. Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder. J Clin Endocrinol Metab 2003;88:5387-5391.
141. Palmiter RD. Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 2007;30:375-381.
142. Cohen M. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 2003;88:4696-4701.
143. Phillipp E. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 1991;48:2443-2450.
144. Murphy KG. Gut hormones and the regulation of energy homeostasis. Nature 2006;444:854-859.
145. Batterhem RL. PYY modulation of cortical and hypothalamic brain areas feeding behaviour in humans. Nature 2007;450:106-109.
146. Doraiswamy PM. Pituitary abnormalities in eating disorders: further evidence from MRI studies. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:351-356.
147. Nunn K. Anorexia nervosa and the insula. Med Hypotheses 2011;76:353-357.